Stevens Christopher James
SEC insider (Form 3/4/5 filer). CIK 0002079768. Chief Operating Officer at ROCKET PHARMACEUTICALS, INC. (RCKT). 4 reported Form 4/5 transactions since Sep 2024; latest on Aug 11, 2026. Located in CRANBURY, NJ.
Companies Stevens Christopher James has filed insider reports for
- ROCKET PHARMACEUTICALS, INC. (RCKT): Officer, Chief Operating Officer
Stevens Christopher James
CIK: 0002079768
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)1 (25.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)3 (75.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
RCKT
ROCKET PHARMACEUTICALS, INC.
Officer
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Aug 11, 2026RCKT
ROCKET PHARMACEUTICALS, INC.
SaleDirect36.7K shares at avg. $3.50$128K - Aug 3, 2026RCKT
ROCKET PHARMACEUTICALS, INC.
AwardDirect73.3K shares- - Feb 11, 2026RCKT
ROCKET PHARMACEUTICALS, INC.
AwardDirect62K shares- - Aug 4, 2025RCKT
ROCKET PHARMACEUTICALS, INC.
AwardDirect407.2K shares-
1-4 of 4 transactions